Secular trends and dynamics of hospital associated methicillin-resistant Staphylococcus aureus

Clinical Microbiology and Infection

Volumn 16, Issue 9, 2010, Pages 1435-1441

  Armand Lefevre, L ^a   Buke, C ^a,b   Ruppe, E ^a   Barbier, F ^a   Lolom, I ^a   Andremont, A ^a   Ruimy, R ^a   Lucet, J C ^a  

^a BICHAT HOSPITAL   (France)

^b EGE UNIVERSITY   (Turkey)

Author keywords

Cross infection; Epidemiology; France; Methicillin resistance; Risk factors; Staphylococcus aureus

Indexed keywords

GENTAMICIN; KANAMYCIN; OFLOXACIN; QUINOLONE DERIVATIVE; TOBRAMYCIN;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; EPIDEMIOLOGICAL DATA; FEMALE; FRANCE; HOSPITAL INFECTION; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MOLECULAR TYPING; MULTILOCUS SEQUENCE TYPING; OBSTETRIC UNIT; PRIORITY JOURNAL; SEX DIFFERENCE; WARD;

METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS AUREUS;

EID: 77956102452     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2010.03138.x     Document Type: Article

References (21)

1. Grundmann H, Aires-de-Sousa M, Boyce J, Tiemersma E. Emergence and resurgence of meticillin-resistant Staphylococcus aureus as a public-health threat. Lancet 2006, 368:874-885.
2. Durand G, Bes M, Meugnier H. Detection of new methicillin-resistant Staphylococcus aureus clones containing the toxic shock syndrome toxin 1 gene responsible for hospital- and community-acquired infections in France. J Clin Microbiol 2006, 44:847-853.
3. Aubry-Damon H, Legrand P, Brun-Buisson C, Astier A, Soussy CJ, Leclercq R. Reemergence of gentamicin-susceptible strains of methicillin-resistant Staphylococcus aureus: roles of an infection control program and changes in aminoglycoside use. Clin Infect Dis 1997, 25:647-653.
4. Lelievre H, Lina G, Jones ME. Emergence and spread in French hospitals of methicillin-resistant Staphylococcus aureus with increasing susceptibility to gentamicin and other antibiotics. J Clin Microbiol 1999, 37:3452-3457.
5. Lucet JC, Paoletti X, Lolom I. Successful long-term program for controlling methicillin-resistant Staphylococcus aureus in intensive care units. Intensive Care Med 2005, 31:1051-1057.
6. Unal S, Hoskins J, Flokowitsch JE, Wu CY, Preston DA, Skatrud PL. Detection of methicillin-resistant staphylococci by using the polymerase chain reaction. J Clin Microbiol 1992, 30:1685-1691.
7. Ruimy R, Dos-Santos M, Raskine L. Accuracy and potential usefulness of triplex real-time PCR for improving antibiotic treatment of patients with blood cultures showing clustered gram-positive cocci on direct smears. J Clin Microbiol 2008, 46:2045-2051.
8. Kondo Y, Ito T, Ma XX. Combination of multiplex PCRs for staphylococcal cassette chromosome mec type assignment: rapid identification system for mec, ccr, and major differences in junkyard regions. Antimicrob Agents Chemother 2007, 51:264-274.
9. Ruimy R, Maiga A, Armand-Lefevre L. The carriage population of Staphylococcus aureus from Mali is composed of a combination of pandemic clones and the divergent Panton-Valentine leukocidin-positive genotype ST152. J Bacteriol 2008, 190:3962-3968.
10. Enright MC, Robinson DA, Randle G, Feil EJ, Grundmann H, Spratt BG. The evolutionary history of methicillin-resistant Staphylococcus aureus (MRSA). Proc Natl Acad Sci USA 2002, 99:7687-7692.
11. Dauwalder O, Lina G, Durand G. Epidemiology of invasive methicillin-resistant Staphylococcus aureus clones collected in France in 2006 and 2007. J Clin Microbiol 2008, 46:3454-3458.
12. Annual report 2008. http://www.rivm.nl/earss/results, EARSS,
13. Laurent F, Lelievre H, Cornu M. Fitness and competitive growth advantage of new gentamicin-susceptible MRSA clones spreading in French hospitals. J Antimicrob Chemother 2001, 47:277-283.
14. van Wamel WJ, Rooijakkers SH, Ruyken M, van Kessel KP, van Strijp JA. The innate immune modulators staphylococcal complement inhibitor and chemotaxis inhibitory protein of Staphylococcus aureus are located on beta-hemolysin-converting bacteriophages. J Bacteriol 2006, 188:1310-1315.
15. de Lassence A, Hidri N, Timsit JF. Control and outcome of a large outbreak of colonization and infection with glycopeptide-intermediate Staphylococcus aureus in an intensive care unit. Clin Infect Dis 2006, 42:170-178.
16. Miller LG, Diep BA. Clinical practice: colonization, fomites, and virulence: rethinking the pathogenesis of community-associated methicillin-resistant Staphylococcus aureus infection. Clin Infect Dis 2008, 46:752-760.
17. Perez-Roth E, Lorenzo-Diaz F, Batista N, Moreno A, Mendez-Alvarez S. Tracking methicillin-resistant Staphylococcus aureus clones during a 5-year period (1998 to 2002) in a Spanish hospital. J Clin Microbiol 2004, 42:4649-4656.
18. Edgeworth JD, Yadegarfar G, Pathak S. An outbreak in an intensive care unit of a strain of methicillin-resistant Staphylococcus aureus sequence type 239 associated with an increased rate of vascular access device-related bacteremia. Clin Infect Dis 2007, 44:493-501.
19. Popovich KJ, Weinstein RA, Hota B. Are community-associated methicillin-resistant Staphylococcus aureus (MRSA) strains replacing traditional nosocomial MRSA strains? Clin Infect Dis 2008, 46:787-794.
20. Tristan A, Bes M, Meugnier H. Global distribution of Panton-Valentine leukocidin - positive methicillin-resistant Staphylococcus aureus, 2006. Emerg Infect Dis 2007, 13:594-600.
21. Felten A, Grandry B, Lagrange PH, Casin I. Evaluation of three techniques for detection of low-level methicillin-resistant Staphylococcus aureus (MRSA): a disk diffusion method with cefoxitin and moxalactam, the Vitek 2 system, and the MRSA-screen latex agglutination test. J Clin Microbiol 2002, 40:2766-2771.